Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial atrial fibrillation in which the cause of the disease is a mutation in the SCN5A gene.
Features include always present findings: Tricuspid regurgitation; and very common findings: Bradycardia. 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 8 | Permanent atrial fibrillation, Stroke, Bradycardia |
SCN5A function has not been fully characterized.
Atrial fibrillation, familial, 10 is associated with mutations in the SCN5A gene on chromosome 3.
Genetic testing for SCN5A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for atrial fibrillation, familial, 10 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 very common feature, 5 common features.
No clinical trials have been registered for atrial fibrillation, familial, 10.
312 publications have been identified in PubMed for atrial fibrillation, familial, 10. Kisho has analyzed 136 by research type. Research spans Epidemiology / Natural History (31%), Review / Meta-Analysis (19%), and Other (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 42 | 31% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 4:33 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
1 |
Stroke |
Research summaries |
26 |
19% |
Other research | 25 | 18% |
Clinical study results | 19 | 14% |
Laboratory research | 13 | 10% |
Testing and diagnosis research | 9 | 7% |
Patient case studies | 2 | 1% |
Li L (2026). [PMID: 41241110](https://pubmed.ncbi.nlm.nih.gov/41241110/). *Heart Rhythm*. [Epidemiology / Natural History]
Nathan AS (2026). [PMID: 41592672](https://pubmed.ncbi.nlm.nih.gov/41592672/). *Heart Rhythm*. [Epidemiology / Natural History]
Bola H (2026). [PMID: 41922901](https://pubmed.ncbi.nlm.nih.gov/41922901/). *Europace*. [Review / Meta-Analysis]
Martínez-Barrios E (2026). [PMID: 41596527](https://pubmed.ncbi.nlm.nih.gov/41596527/). *Int J Mol Sci*. [Basic Science / Preclinical]
Dulal D (2026). [PMID: 41004619](https://pubmed.ncbi.nlm.nih.gov/41004619/). *Eur Heart J Qual Care Clin Outcomes*. [Epidemiology / Natural History]
Nakashima K (2026). [PMID: 40996829](https://pubmed.ncbi.nlm.nih.gov/40996829/). *Eur Heart J*. [Basic Science / Preclinical]
Jiang C (2026). [PMID: 41206792](https://pubmed.ncbi.nlm.nih.gov/41206792/). *Circulation*. [Clinical Trial Publication]
Tabaja C (2026). [PMID: 41412419](https://pubmed.ncbi.nlm.nih.gov/41412419/). *Heart Rhythm*. [Clinical Trial Publication]
Rankinen J (2026). [PMID: 40664496](https://pubmed.ncbi.nlm.nih.gov/40664496/). *Heart*. [Epidemiology / Natural History]
Pambrun T (2026). [PMID: 41860501](https://pubmed.ncbi.nlm.nih.gov/41860501/). *JACC Clin Electrophysiol*. [Review / Meta-Analysis]